GC
GPCR icon

Gilbert & Cook’s Structure Therapeutics GPCR Stock Holding History

Gilbert & Cook’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Sell
9,167
-26
-0.3% -$1.15K 0.06% 160
2026
Q1 		$443K Buy
9,193
+3,511
+62% +$240K 0.06% 157
2025
Q4 		$395K Buy
+5,682
New +$232K 0.05% 171
2024
Q4 		– Sell
-5,682
Closed -$249K – 206
2024
Q3 		$249K Sell
5,682
-148
-3% -$5.72K 0.03% 195
2024
Q2 		$229K Buy
+5,830
New +$239K 0.03% 197

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Gilbert & Cook's GPCR Position: Q2 2026 in Review

Gilbert & Cook reduced its Structure Therapeutics (GPCR) stake by 0.28% in Q2 2026, selling an estimated $1.15K and leaving 9,167 shares worth $492K. The position accounts for 0.06% of the portfolio, ranked #160.

Gilbert & Cook first reported a position in GPCR in Q2 2024 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Gilbert & Cook held 9,167 shares of Structure Therapeutics worth $492K as of Q2 2026.
  • Gilbert & Cook sold 26 Structure Therapeutics shares in Q2 2026, an estimated $1.15K.
  • Structure Therapeutics made up 0.06% of Gilbert & Cook's portfolio in Q2 2026, its #160 holding.
  • Gilbert & Cook first reported a position in Structure Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.